» Articles » PMID: 28679753

On the Death Rate of Abortively Infected Cells: Estimation from Simian-Human Immunodeficiency Virus Infection

Overview
Journal J Virol
Date 2017 Jul 7
PMID 28679753
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Progressive T cell depletion during chronic human immunodeficiency virus type 1 (HIV) infection is a key mechanism that leads to the development of AIDS. Recent studies have suggested that most T cells in the tissue die through pyroptosis triggered by abortive infection, i.e., infection of resting T cells in which HIV failed to complete reverse transcription. However, the contribution of abortive infection to T cell loss and how quickly abortively infected cells die , key parameters for a quantitative understanding of T cell population dynamics, are not clear. Here, we infected rhesus macaques with simian-human immunodeficiency viruses (SHIV) and followed the dynamics of both plasma SHIV RNA and total cell-associated SHIV DNA. Fitting mathematical models to the data, we estimate that upon infection a majority of CD4 T cells (approximately 65%, on average) become abortively infected and die at a relatively high rate of 0.27 day (half-life, 2.6 days). This confirms the importance of abortive infection in driving T cell depletion. Further, we find evidence suggesting that an immune response may be restricting viral infection 1 to 3 weeks after infection. Our study serves as a step forward toward a quantitative understanding of the mechanisms driving T cell depletion during HIV infection. In HIV-infected patients, progressive CD4 T cell loss ultimately leads to the development of AIDS. The mechanisms underlying this T cell loss are not clear. Recent experimental data suggest that the majority of CD4 T cells in tissue die through abortive infection, where the accumulation of incomplete HIV transcripts triggers cell death. To investigate the role of abortive infection in driving CD4 T cell loss , we infected macaques with simian-human immunodeficiency viruses (SHIV) and followed the viral kinetics of both plasma RNA and cell-associated DNA during infection. Fitting mathematical models, we estimated that a large fraction of infected cells dies through abortive infection and has a half-life of approximately 2.6 days. Our results provide the first quantitative estimates of parameters characterizing abortive infection and support the notion that abortive infection represents an important mechanism underlying progressive CD4 T cell depletion .

Citing Articles

Abortive infection of bat fibroblasts with SARS-CoV-2.

Bisht P, Gallagher M, Barrasa M, Boucau J, Harding A, Dejosez M Proc Natl Acad Sci U S A. 2024; 121(43):e2406773121.

PMID: 39401365 PMC: 11513954. DOI: 10.1073/pnas.2406773121.


Antiviral capacity of the early CD8 T-cell response is predictive of natural control of SIV infection: Learning in vivo dynamics using ex vivo data.

Vemparala B, Madelain V, Passaes C, Millet A, Avettand-Fenoel V, Djidjou-Demasse R PLoS Comput Biol. 2024; 20(9):e1012434.

PMID: 39255323 PMC: 11414924. DOI: 10.1371/journal.pcbi.1012434.


Modeling resistance to the broadly neutralizing antibody PGT121 in people living with HIV-1.

Cassidy T, Stephenson K, Barouch D, Perelson A PLoS Comput Biol. 2024; 20(3):e1011518.

PMID: 38551976 PMC: 11006161. DOI: 10.1371/journal.pcbi.1011518.


Healthy dynamics of CD4 T cells may drive HIV resurgence in perinatally-infected infants on antiretroviral therapy.

Morris S, Strehlau R, Shiau S, Abrams E, Tiemessen C, Kuhn L PLoS Pathog. 2022; 18(8):e1010751.

PMID: 35969641 PMC: 9410541. DOI: 10.1371/journal.ppat.1010751.


Estimation of the in vivo neutralization potency of eCD4Ig and conditions for AAV-mediated production for SHIV long-term remission.

Goyal A, Gardner M, Mayer B, Jerome K, Farzan M, Schiffer J Sci Adv. 2022; 8(2):eabj5666.

PMID: 35020436 PMC: 8754410. DOI: 10.1126/sciadv.abj5666.


References
1.
Galloway N, Doitsh G, Monroe K, Yang Z, Munoz-Arias I, Levy D . Cell-to-Cell Transmission of HIV-1 Is Required to Trigger Pyroptotic Death of Lymphoid-Tissue-Derived CD4 T Cells. Cell Rep. 2015; 12(10):1555-1563. PMC: 4565731. DOI: 10.1016/j.celrep.2015.08.011. View

2.
Koup R, Safrit J, Cao Y, Andrews C, McLeod G, Borkowsky W . Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J Virol. 1994; 68(7):4650-5. PMC: 236393. DOI: 10.1128/JVI.68.7.4650-4655.1994. View

3.
Cong M, Youngpairoj A, Zheng Q, Aung W, Mitchell J, Sweeney E . Protection against rectal transmission of an emtricitabine-resistant simian/human immunodeficiency virus SHIV162p3M184V mutant by intermittent prophylaxis with Truvada. J Virol. 2011; 85(15):7933-6. PMC: 3147931. DOI: 10.1128/JVI.00843-11. View

4.
Zhou Y, Zhang H, Siliciano J, Siliciano R . Kinetics of human immunodeficiency virus type 1 decay following entry into resting CD4+ T cells. J Virol. 2005; 79(4):2199-210. PMC: 546571. DOI: 10.1128/JVI.79.4.2199-2210.2005. View

5.
Doitsh G, Galloway N, Geng X, Yang Z, Monroe K, Zepeda O . Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection. Nature. 2013; 505(7484):509-14. PMC: 4047036. DOI: 10.1038/nature12940. View